Ridgeback Capital Owns 6% of Celldex
From Insider Monkey - Free Hedge Fund and Insider Trading Data
December 31, 2013 - 10:37am
A 13G filing has disclosed that Ridgeback Capital, a healthcare focused hedge fund managed by Wayne Holman, has acquired a total of 3.8 million shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX). This gives it over 6% of the $410 million market cap pharmaceutical company’s total shares outstanding. Ridgeback had reported owning 2.9 million shares of the [...]
Continue reading this article »Share This Article: